New lab technology could reveal treatments for muscle-wasting disease | DuchenneXchange

welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

New lab technology could reveal treatments for muscle-wasting disease


Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.

The new approach, led by Dr Yung-Yao Lin from Queen Mary’s Blizard Institute and supported by Professor Andy Tinker from Queen Mary’s William Harvey Research Institute, uses the latest advances in gene editing and stem cell technology to develop a model of human cells with DMD which mimic what happens in a patient’s muscles.

https://www.duchennexchange.org/wp-content/uploads/2018/06/Cardiomyocytes-derived-from-human.jpg